SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Autonomix Medical, Inc. (AMIX) Gets FDA Feedback Supporting 510(k) Path

Autonomix said FDA pre-submission feedback supports a Class II substantial-equivalence 510(k) pathway for its standalone sensing platform, with potential U.S. clearance targeted in approximately 15 months, subject to development, validation and FDA review.Material DetailsContext by AI AnalystEarly…

AMIX

Related stories